97 related articles for article (PubMed ID: 20118171)
1. Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials.
Onuma Y; Serruys PW; Kukreja N; Veldhof S; Doostzadeh J; Cao S; Stone GW;
Eur Heart J; 2010 May; 31(9):1071-8. PubMed ID: 20118171
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial.
Stone GW; Rizvi A; Sudhir K; Newman W; Applegate RJ; Cannon LA; Maddux JT; Cutlip DE; Simonton CA; Sood P; Kereiakes DJ;
J Am Coll Cardiol; 2011 Jun; 58(1):19-25. PubMed ID: 21514084
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.
Hermiller JB; Sudhir K; Applegate RJ; Rizvi A; Wang J; Gordon PC; Yaqub M; Cao S; Ferguson JM; Smith RS; Sood P; Stone GW
EuroIntervention; 2012 May; 8(1):87-93. PubMed ID: 22580252
[TBL] [Abstract][Full Text] [Related]
5. 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial).
Smits PC; Kedhi E; Royaards KJ; Joesoef KS; Wassing J; Rademaker-Havinga TA; McFadden E
J Am Coll Cardiol; 2011 Jun; 58(1):11-8. PubMed ID: 21514083
[TBL] [Abstract][Full Text] [Related]
6. Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials.
Ito H; Hermiller JB; Yaqub M; Newman W; Sood P; Wang JC; Cannon L; Maddux JE; Sudhir K; Stone GW
J Interv Cardiol; 2011 Dec; 24(6):505-13. PubMed ID: 21919955
[TBL] [Abstract][Full Text] [Related]
7. Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).
Applegate RJ; Yaqub M; Hermiller JB; Sood P; Yu S; Doostzadeh J; Williams JE; Farhat N; Caputo R; Lansky AJ; Cutlip DE; Sudhir K; Stone GW
Am J Cardiol; 2011 Mar; 107(6):833-40. PubMed ID: 21247538
[TBL] [Abstract][Full Text] [Related]
8. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.
Zhang F; Dong L; Qian J; Ge J
Ann Med; 2011 Feb; 43(1):75-9. PubMed ID: 21171912
[TBL] [Abstract][Full Text] [Related]
10. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Applegate RJ; Hermiller JJ; Sanz M; Doostzadeh J; Pierson W; Su X; Lansky AJ; Sudhir K; Stone GW
EuroIntervention; 2010 Sep; 6(4):437-46. PubMed ID: 20884430
[TBL] [Abstract][Full Text] [Related]
11. Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial).
Ng VG; Lansky AJ; Hermiller JB; Farhat N; Applegate RJ; Yaqub M; Sood P; Su X; Simonton CA; Sudhir K; Stone GW
Am J Cardiol; 2011 Mar; 107(6):841-8. PubMed ID: 21255760
[TBL] [Abstract][Full Text] [Related]
12. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW;
J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
15. Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.
Kereiakes DJ; Smits PC; Kedhi E; Parise H; Fahy M; Serruys PW; Stone GW
EuroIntervention; 2011 May; 7(1):74-83. PubMed ID: 21550906
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).
Kereiakes DJ; Cutlip DE; Applegate RJ; Wang J; Yaqub M; Sood P; Su X; Su G; Farhat N; Rizvi A; Simonton CA; Sudhir K; Stone GW
J Am Coll Cardiol; 2010 Dec; 56(25):2084-9. PubMed ID: 21144968
[TBL] [Abstract][Full Text] [Related]
18. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.
Chieffo A; Park SJ; Meliga E; Sheiban I; Lee MS; Latib A; Kim YH; Valgimigli M; Sillano D; Magni V; Biondi-Zoccai G; Montorfano M; Airoldi F; Rogacka R; Carlino M; Michev I; Lee CW; Hong MK; Park SW; Moretti C; Bonizzoni E; Sangiorgi GM; Tobis J; Serruys PW; Colombo A
Eur Heart J; 2008 Sep; 29(17):2108-15. PubMed ID: 18565967
[TBL] [Abstract][Full Text] [Related]
19. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
[TBL] [Abstract][Full Text] [Related]
20. Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.
Kedhi E; Stone GW; Kereiakes DJ; Serruys PW; Parise H; Fahy M; Simonton CA; Sudhir K; Sood P; Smits PC
EuroIntervention; 2012 Sep; 8(5):599-606. PubMed ID: 22995087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
